brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
methotrexate pfizer (methotrexate wyeth) tafla 2,5 mg
pfizer aps - methotrexatum inn - tafla - 2,5 mg
requip depot forðatafla 2 mg
glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 2 mg
requip depot forðatafla 4 mg
glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 4 mg
requip depot forðatafla 8 mg
glaxosmithkline pharma a/s - ropinirolum hýdróklóríð - forðatafla - 8 mg
ropinirole alvogen (ropinirole portfarma) forðatafla 2 mg
alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 2 mg
ropinirole alvogen (ropinirole portfarma) forðatafla 4 mg
alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 4 mg
ropinirole alvogen (ropinirole portfarma) forðatafla 8 mg
alvogen ehf. - ropinirolum hýdróklóríð - forðatafla - 8 mg
erlotinib wh filmuhúðuð tafla 100 mg
williams & halls ehf. - erlotinibum hýdróklóríð - filmuhúðuð tafla - 100 mg
erlotinib wh filmuhúðuð tafla 150 mg
williams & halls ehf. - erlotinibum hýdróklóríð - filmuhúðuð tafla - 150 mg